A small trial of a cholesterol-lowering treatment based on CRISPR gene editing has produced promising results, but there are questions over safety
A small trial of a cholesterol-lowering treatment based on CRISPR gene editing has produced promising results, but there are questions over safety A small trial of a cholesterol-lowering treatment based on CRISPR gene editing has produced promising results, but there are questions over safety